Bacteriophage infecting the myxobacterium Chondrococcus columnaris.
Kingsbury, David T. (University of Washington, Seattle), and Erling J. Ordal. Bacteriophage infecting the myxobacterium Chondrococcus columnaris. J. Bacteriol. 91:1327-1332. 1966.-During a series of screening experiments, seven bacteriophages which infect the pathogenic myxobacterium Chondrococcus columnaris were isolated. Of these, one was chosen for detailed study. This phage has a wide host range among strains of C. columnaris, but does not infect other myxobacterial species tested. Morphologically, this phage resembles coliphage T2, though it is smaller. It has a head diameter of 600 A, a tail length of 1,000 A, and a tail width of 200 A. The head is attached to the tail by a well-defined neck. The turbid plaques produced by this phage are similar in appearance to those produced by coliphage lambda, and average 1 mm in diameter. The phage has a latent period of 100 min, a rise period of an additional 90 min, and a burst size of 23. Calcium ions at a concentration of 0.004 m are required for adsorption. This requirement cannot be met by substitution of magnesium ions. A purified preparation of 2 x 10(12) phage particles was extracted with phenol, and the nucleic acid was identified as deoxyribonucleic acid (DNA). Base ratios of the phage DNA and the DNA of two propagating strains were similar. Streptomycin at a concentration of 70 mug/ml inhibits phage infection at an early stage, probably by inhibiting injection of the phage DNA.
D000327:Adsorption; D001419:Bacteria; D001435:Bacteriophages; D002118:Calcium; D003090:Coliphages; D004279:DNA, Viral; D066298:In Vitro Techniques; D008274:Magnesium; D008854:Microscopy, Electron; D012965:Sodium Chloride / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology
D004279:DNA, Viral; D012965:Sodium Chloride; D008274:Magnesium; D002118:Calcium; D013307:Streptomycin